Strategic positioning Compass Research operates across multiple therapeutic areas with a strong emphasis on Alzheimer's disease and neurodegenerative research, presenting a compelling partner profile for sponsors seeking specialized CNS trials and longitudinal studies.

Clinical scale With 51-200 employees and facilities in Orlando, The Villages, and Melbourne, Compass offers scalable site operations for Phase 0–4 trials, enabling sponsors to conduct multi-site, patient-centric studies efficiently.

Wide sponsor network Having completed over 1,300 clinical trials for more than 200 industry sponsors signals a proven track record, enabling business development efforts to target both emerging biotech partners and large pharma with confidence.

Quality credentials Board-certified physicians and seasoned clinical research coordinators, combined with a reputation for patient care and integrity, support proposals around high-quality data, patient recruitment, and regulatory compliance.

Tech enablement Adoption of modern tech stack including Google Cloud and OpenResty suggests opportunities to position Compass for cloud-based data management, remote monitoring, and scalable analytics collaborations with sponsors seeking digital trial capabilities.